Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I CA125 and anti-CA125

• Glavni autori: Szu-Ting Yang (Autor), Wen-Hsun Chang (Autor), Fang-Wei Chou (Autor), Hung-Hsien Liu (Autor), Wen-Ling Lee (Autor), Peng-Hui Wang (Autor)
• Format: Knjiga
• Izdano: Elsevier, 2023-11-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

The current standard therapy of epithelial ovarian cancer (EOC) is the combination of surgery (primary cytoreductive surgery or interval cytoreductive surgery) and platinum-based chemotherapy (mainly using paclitaxel and carboplatin either by neoadjuvant chemotherapy and/or by postoperative adjuvant...